Incannex Healthcare (IHL AU): Attractive Idea Backed by Niche Focus on Cannabinoid Pharmaceuticals
Incannex has 28+ drug candidates for broad range of under-met medical conditions representing major economic opportunities. The company is well...
326 Views
S&P/ASX Index Rebalance (Sep 2022): Adds, Deletes, Surprises & Pre-Positioning
There are a lot of changes to the ASX200 and ASX300 indices with high impact. There are a few surprises, mainly in the ASX300. Shorts have surged...
543 Views
Incannex Healthcare - Addressing unmet needs via alternative approach
Incannex Healthcare is an Australian biotech specializing in the development of treatments for chronic conditions through a unique approach....
671 Views
Incannex Healthcare - APIRx acquisition to bolster portfolio
Incannex Healthcare, an Australian cannabinoid and psychedelic medicines biotech, has announced that it has completed the acquisition of APIRx...
663 Views